HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subanesthetic isoflurane abates ROS-activated MAPK/NF-κB signaling to repress ischemia-induced microglia inflammation and brain injury.

Abstract
Isoflurane (ISO) elicits protective effects on ischemia-induced brain injury. We investigated whether sub-anesthetic (0.7%) ISO post-conditioning attenuates the inflammation and apoptosis in oxygen-glucose deprivation (OGD)-insulted co-cultures (microglia and neurons) in vitro and the brain injury of the middle cerebral arterial occlusion (MCAO) rat. We demonstrated that ISO augmented the viability of OGD-treated microglia and neurons. ISO reduced the expression and activation of COX2 and iNOS in OGD-challenged microglia. ISO repressed the production of tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-8, and monocyte chemoattractant protein-1 in OGD-exposed microglia. ISO also decreased nucleosomal fragmentation and caspase-3 activity but increased mitochondrial membrane potential in OGD-stimulated microglia and neurons. Mechanistically, ISO suppressed OGD-induced microglial inflammation by blocking ROS-regulated p38 MAPK/NF-κB signaling pathway and hampered OGD-triggered microglial apoptosis in a ROS- or NO-dependent fashion. In vivo results with MCAO rats were partly consistent with the in vitro observation. These findings indicate that sub-anesthetic ISO post-conditioning abates the inflammation and apoptosis in OGD-stimulated rat microglia and the apoptosis of OGD-exposed neurons and the brain injuries of MCAO rats, suggesting it as a potentially effective therapeutic approach for ischemic brain damages.
AuthorsZhiqiang Yao, Ningning Liu, Xiaoshan Zhu, Ling Wang, Yali Zhao, Qinqin Liu, Chunfang Gao, Juntang Li
JournalAging (Aging (Albany NY)) Vol. 12 Issue 24 Pg. 26121-26139 (12 28 2020) ISSN: 1945-4589 [Electronic] United States
PMID33373319 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anesthetics, Inhalation
  • Ccl2 protein, rat
  • Chemokine CCL2
  • IL1B protein, rat
  • Il6 protein, rat
  • Interleukin-1beta
  • Interleukin-6
  • Interleukin-8
  • NF-kappa B
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Isoflurane
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Anesthetics, Inhalation (pharmacology)
  • Animals
  • Apoptosis (drug effects)
  • Brain Ischemia (metabolism)
  • Chemokine CCL2 (drug effects, metabolism)
  • Coculture Techniques
  • Cyclooxygenase 2 (drug effects, metabolism)
  • Disease Models, Animal
  • Infarction, Middle Cerebral Artery
  • Inflammation (metabolism)
  • Interleukin-1beta (drug effects, metabolism)
  • Interleukin-6 (metabolism)
  • Interleukin-8 (drug effects, metabolism)
  • Isoflurane (pharmacology)
  • Microglia (drug effects, metabolism)
  • NF-kappa B (drug effects, metabolism)
  • Neurons (drug effects, metabolism)
  • Nitric Oxide Synthase Type II
  • Rats
  • Reactive Oxygen Species (metabolism)
  • Tumor Necrosis Factor-alpha (drug effects, metabolism)
  • p38 Mitogen-Activated Protein Kinases (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: